Table 1 Characteristics of patients [median (Q1, Q3) or no. (%)].
Variable | MSI (n = 68) | MSS (n = 239) | P value |
|---|---|---|---|
Gender | 0.077 | ||
Male | 34 | 148 | |
Female | 34 | 91 | |
Age (years) | 64 (53, 73) | 63 (55, 71) | 0.741 |
Hypertension | 0.009 | ||
Presence | 16 (23.53%) | 98 (41.00%) | |
Absence | 52 (76.47%) | 141(59.00%) | |
Diabetes | 0.196 | ||
Presence | 11 (16.18%) | 25 (10.46%) | |
Absence | 57 (83.82%) | 214 (89.54%) | |
Tumor location | < 0.001 | ||
Right colon | 43 (63.23%) | 75 (31.38%) | |
Left colon | 13 (19.12%) | 45 (18.83%) | |
Rectum | 12 (17.65%) | 119 (49.79%) | |
T stage | 0.707 | ||
T1 ~ 2 | 9 (13.24%) | 36 (15.06%) | |
T3 ~ 4 | 59 (86.76%) | 203 (84.94%) | |
N stage | < 0.001 | ||
N0 | 55 (80.88%) | 113 (47.28%) | |
N1 ~ 2 | 13 (19.12%) | 126 (52.72%) | |
M stage | 0.344 | ||
M0 | 68 (100.00%) | 233 (97.49%) | |
M1 | 0 (0.00%) | 6 (2.51%) | |
CEA (ng/ml) | 2.22 (0.94, 4.13) | 2.65 (1.43, 6.46) | 0.074 |
CA125 (U/ml) | 8.95 (6.20, 16.48) | 8.00 (5.10, 11.30) | 0.061 |
CA199 (U/ml) | 15.65 (7.44, 25.98) | 12.26 (7.15, 30.49) | 0.483 |
